Asia · Regional markets · Business Standard

AIR-STEMI Trial Shows Physiology-guided Complete Revascularisation Reduced Cardiovascular Events in Patients with STEMI and Multivessel Disease

Published by Business Standard · India 16 h ago

Sahajanand Medical Technologies (SMT) highlighted results from AIR-STEMI, an investigator-initiated, multicentre, randomised clinical trial in patients with ST-segment elevation…

Read the full article on Business Standard Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.business-standard.com)

Also worth reading

CNBC-TV18

Sensex Today | Stock Market Live Updates: Nifty rises above 22,700; Birlasoft surges 10%

Tech in Asia

50 rising greentech startups in Asia

The Straits Times Business

These mid-career workers are back in class to learn AI. Is it paying off?

The Business Times

Wilmar slides more than 4% after weaker Q3 earnings; Indonesian police probe plantation fires

Mint

Top stock to buy today: Jefferies India sees 29% upside in NSE share price in upside scenario | Target price, rationale

The Edge (Singapour et Malaisie)